Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 02-2004 | 11-2003 | 08-2003 | 05-2003 | 02-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 120 | 220 | 600 | 130 |
| Receivables | 80 | 80 | 70 | 60 | 50 |
| Other current assets | 70 | 80 | 60 | 60 | 100 |
| TOTAL | $170 | $280 | $350 | $720 | $280 |
| Non-Current Assets | |||||
| PPE Net | 4,080 | N/A | 4,050 | N/A | N/A |
| Other Non-Current Assets | 3,720 | 4,060 | 4,450 | 6,370 | 6,680 |
| TOTAL | $7,800 | $4,060 | $8,500 | $6,370 | $6,680 |
| Total Assets | $4,520 | $5,120 | $5,710 | $8,180 | $8,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 270 | 330 | 290 | 820 | 780 |
| Other current liabilities | 20 | 10 | 10 | 200 | 180 |
| TOTAL | $560 | $460 | $900 | $1,480 | $1,300 |
| Non-Current Liabilities | |||||
| TOTAL | $6 | $7 | $7 | $10 | $N/A |
| Total Liabilities | $570 | $470 | $900 | $1,490 | $1,300 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 20 | 30 | 10 |
| Retained earnings | -30,830 | -29,950 | -28,580 | -27,620 | -26,160 |
| Other shareholders' equity | 90 | 90 | 100 | 410 | 30 |
| TOTAL | $3,950 | $4,650 | $4,810 | $6,680 | $6,910 |
| Total Liabilities And Equity | $4,520 | $5,120 | $5,710 | $8,170 | $8,210 |